Recent Advances in Neuroinflammation Therapeutics: PPARs/LXR as Neuroinflammatory Modulators
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
1312-1323
Author(s):
Sussy Bastias-Candia, Nicolas Garrido A., Juan M. Zolezzi and Nibaldo C. Inestrosa
Microglia in Alzheimer's Disease: The Good, the Bad and the Ugly
Journal:
Current Alzheimer Research
Volume:
13
Page:
370-380
Author(s):
Dario Tejera and Michael T. Heneka
Novel Therapeutic Strategies for Dementia
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
15
Page:
141-241
Author(s):
Ramón Cacabelos, Clara Torrellas, Iván Carrera, Pablo Cacabelos, Lola Corzo, Lucía Fernández-Novoa, Iván Tellado, Juan C. Carril and Gjumrakch Aliev
Alzheimer's disease: Targeting the Cholinergic System
Journal:
Current Neuropharmacology
Volume:
14
Page:
101-115
Author(s):
Talita H. Ferreira-Vieira, Isabella M. Guimaraes, Flavia R. Silva and Fabiola M. Ribeiro
Development of a Novel and Robust Pharmacological Model of Okadaic Acid-induced Alzheimer’s Disease in Zebrafish
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
15
Page:
86-94
Author(s):
Shadia E. Nada, Frederick E. Williams and Zahoor A. Shah
Neurogenic plasticity of mesenchymal stem cell, an alluring cellular replacement for traumatic brain injury
Journal:
Current Stem Cell Research & Therapy
Volume:
11
Page:
149-157
Author(s):
Soumya Pati, Sangu Muthuraju, Raisah Ab. Hadi, Tee Jong Huat, Shailja Singh, Mirjana Maletic-Savatic, Jafri Malin Abdullah and Hasnan Jaafar
PERK-opathies: An Endoplasmic Reticulum Stress Mechanism Underlying Neurodegeneration
Journal:
Current Alzheimer Research
Volume:
13
Page:
150-163
Author(s):
Michelle C. Bell, Shelby E. Meier, Alexandria L. Ingram and Jose F. Abisambra
Therapeutic Targeting of the FKBP52 Co-Chaperone in Steroid Hormone Receptor-Regulated Physiology and Disease
Journal:
Current Molecular Pharmacology
Volume:
9
Page:
109-125
Author(s):
Naihsuan C. Guy, Yenni A. Garcia and Marc B. Cox
Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets – Part II)
Journal:
Current Molecular Pharmacology
Volume:
9
Page:
97-180
Author(s):
Mario D. Galigniana
Noradrenergic System in Down Syndrome and Alzheimer’s Disease A Target for Therapy
Journal:
Current Alzheimer Research
Volume:
13
Page:
68-83
Author(s):
Cristy Phillips, Atoossa Fahimi, Devsmita Das, Fatemeh S. Mojabi, Ravikumar Ponnusamy and Ahmad Salehi